Les maladies auto-immunes augmentent-elles le risque de gammaglobulines ?
Oui, elles peuvent entraîner une production anormale d'anticorps et des déséquilibres.
Maladies auto-immunesAnticorps
#5
Le stress peut-il affecter les niveaux de gammaglobulines ?
Oui, le stress chronique peut affaiblir le système immunitaire et affecter la production.
StressSystème immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gammaglobulines : Questions médicales les plus fréquentes",
"headline": "Gammaglobulines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gammaglobulines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gammaglobulines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Immunoglobulines",
"url": "https://questionsmedicales.fr/mesh/D007136",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines",
"code": {
"@type": "MedicalCode",
"code": "D007136",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gammaglobulines",
"alternateName": "gamma-Globulins",
"code": {
"@type": "MedicalCode",
"code": "D005719",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sadeep Shrestha",
"url": "https://questionsmedicales.fr/author/Sadeep%20Shrestha",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Howard W Wiener",
"url": "https://questionsmedicales.fr/author/Howard%20W%20Wiener",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sabrina Chowdhury",
"url": "https://questionsmedicales.fr/author/Sabrina%20Chowdhury",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hidemi Kajimoto",
"url": "https://questionsmedicales.fr/author/Hidemi%20Kajimoto",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Vinodh Srinivasasainagendra",
"url": "https://questionsmedicales.fr/author/Vinodh%20Srinivasasainagendra",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validity of the revised Diagnostic and Statistical Manual of Mental Disorders-5 cross-cutting symptom measure as implemented in community mental health settings.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37844781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrater reliability of criterion A of the alternative model for personality disorder (Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition-Section III): A meta-analysis.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/31803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychopathy and antisocial personality disorder in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders: An attempted replication of Wygant et al. (2016).",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Gammaglobulines",
"item": "https://questionsmedicales.fr/mesh/D005719"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gammaglobulines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gammaglobulines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gammaglobulines",
"description": "Comment mesurer les gammaglobulines dans le sang ?\nQuels tests diagnostiques sont utilisés pour les gammaglobulines ?\nQuels signes indiquent une anomalie des gammaglobulines ?\nQuel rôle joue l'immunoglobuline dans le diagnostic ?\nComment interpréter des niveaux élevés de gammaglobulines ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gammaglobulines",
"description": "Quels symptômes sont liés à des niveaux bas de gammaglobulines ?\nComment les gammaglobulines affectent-elles le système immunitaire ?\nQuels symptômes peuvent indiquer une hypergammaglobulinémie ?\nLes gammaglobulines peuvent-elles causer des symptômes neurologiques ?\nQuels signes cliniques sont associés à une carence en gammaglobulines ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gammaglobulines",
"description": "Comment prévenir les infections chez les patients avec faibles gammaglobulines ?\nLes gammaglobulines peuvent-elles être administrées préventivement ?\nQuelles mesures de prévention sont recommandées ?\nLes patients doivent-ils éviter certains aliments ?\nComment le mode de vie influence-t-il les niveaux de gammaglobulines ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gammaglobulines",
"description": "Comment traiter une carence en gammaglobulines ?\nQuels médicaments augmentent les gammaglobulines ?\nY a-t-il des effets secondaires aux traitements par gammaglobulines ?\nQuelle est la durée du traitement par gammaglobulines ?\nLes gammaglobulines sont-elles utilisées en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gammaglobulines",
"description": "Quelles complications peuvent survenir avec une hypergammaglobulinémie ?\nLes gammaglobulines peuvent-elles causer des complications rénales ?\nQuels sont les risques d'une surdose de gammaglobulines ?\nComment les gammaglobulines affectent-elles la grossesse ?\nQuelles complications peuvent survenir après un traitement par gammaglobulines ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gammaglobulines",
"description": "Quels facteurs augmentent le risque de carence en gammaglobulines ?\nLes personnes âgées sont-elles à risque de faibles gammaglobulines ?\nQuels médicaments peuvent réduire les niveaux de gammaglobulines ?\nLes maladies auto-immunes augmentent-elles le risque de gammaglobulines ?\nLe stress peut-il affecter les niveaux de gammaglobulines ?",
"url": "https://questionsmedicales.fr/mesh/D005719?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer les gammaglobulines dans le sang ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par un dosage sanguin des protéines plasmatiques, souvent via une électrophorèse."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés pour les gammaglobulines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse des protéines et les dosages spécifiques d'anticorps."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une anomalie des gammaglobulines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections fréquentes, des maladies auto-immunes ou des troubles hématologiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'immunoglobuline dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à identifier les déficits immunitaires ou les maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Comment interpréter des niveaux élevés de gammaglobulines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela peut indiquer une infection chronique, une inflammation ou un myélome multiple."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des niveaux bas de gammaglobulines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections récurrentes, fatigue, et parfois des symptômes auto-immuns."
}
},
{
"@type": "Question",
"name": "Comment les gammaglobulines affectent-elles le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont essentielles pour la reconnaissance et la neutralisation des pathogènes."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une hypergammaglobulinémie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs osseuses, et symptômes liés à des infections fréquentes."
}
},
{
"@type": "Question",
"name": "Les gammaglobulines peuvent-elles causer des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être associés à des neuropathies ou des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une carence en gammaglobulines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Signes d'infections fréquentes, retard de croissance chez les enfants, et fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections chez les patients avec faibles gammaglobulines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des vaccinations appropriées et des soins d'hygiène rigoureux."
}
},
{
"@type": "Question",
"name": "Les gammaglobulines peuvent-elles être administrées préventivement ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour les patients immunodéprimés ou à risque élevé d'infections."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules, se laver les mains fréquemment et consulter un médecin rapidement."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains aliments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les aliments crus ou mal cuits pour réduire le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il les niveaux de gammaglobulines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, avec une bonne nutrition et de l'exercice, peut soutenir l'immunité."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en gammaglobulines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des perfusions d'immunoglobulines intraveineuses ou sous-cutanées."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent les gammaglobulines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunoglobulines humaines sont souvent utilisées pour traiter les déficits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements par gammaglobulines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques, des douleurs au site d'injection ou des maux de tête."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement par gammaglobulines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la condition, mais peut être continu ou intermittent selon les besoins."
}
},
{
"@type": "Question",
"name": "Les gammaglobulines sont-elles utilisées en prévention ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être administrées pour prévenir les infections chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hypergammaglobulinémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Risques accrus d'infections, de maladies auto-immunes et de troubles sanguins."
}
},
{
"@type": "Question",
"name": "Les gammaglobulines peuvent-elles causer des complications rénales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surcharge de gammaglobulines peut entraîner des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surdose de gammaglobulines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves, des troubles de la coagulation et des infections."
}
},
{
"@type": "Question",
"name": "Comment les gammaglobulines affectent-elles la grossesse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être administrées pour traiter des infections ou des déficits immunitaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après un traitement par gammaglobulines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires comme des maux de tête, des douleurs musculaires ou des réactions cutanées."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en gammaglobulines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies génétiques, les infections chroniques et certains traitements médicaux."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque de faibles gammaglobulines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la production d'anticorps et l'immunité."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent réduire les niveaux de gammaglobulines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunosuppresseurs et certains traitements anticancéreux peuvent les diminuer."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque de gammaglobulines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner une production anormale d'anticorps et des déséquilibres."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter les niveaux de gammaglobulines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affaiblir le système immunitaire et affecter la production."
}
}
]
}
]
}
The purpose of this study was to validate the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Cross-Cutting Symptom Measure (CCSM) as a screening tool for a wide variety of disorders w...
Participants (N = 851) were referred for coordinated specialty care services (mean age = 20.26 years (SD = 2.97); 82.5 % Caucasian, 7.5 % African American, 0.7 % Native American, 0.7 % Pacific Islande...
At optimal cut-score, specificity ranged from 57 to 77 % for depression, anxiety, substance use and psychosis domains; sensitivity ranged from 63 to 72 %. Scores for depression, anxiety, substance use...
Criterion measures did not have inter-rater reliabilities as this is generally prohibitive in clinic settings....
The CCSM could provide a first step in screening for multiple disorders; however, it cannot replace structured interviews for making diagnoses related to these conditions....
The alternative model for personality disorder (AMPD) is currently included in Section III of the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). This review sought to s...
Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative a...
Our goals were (1) to describe screen uses in a general population sample and (2) to test the unidimensionality, local independence, and psychometric properties of the 9 Diagnostic and Statistical Man...
This cross-sectional survey in a French suburban city targeted adults and adolescents. A self-administered questionnaire covered the main types of screens used and their use for various activities in ...
Among the 300 participants, 171 (57.0%) were female (mean age 27 years), 297 (99.0%) used screens, 134 (44.7%) reported at least one criterion (potential problem users), and 5 (1.7%) reported 5 or mor...
We described screen uses in a French community sample and have shown that the adaptation of the DSM-5 IGD to "ScUD" has good psychometric validity and is discriminating, confirming our hypothesis. We ...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care ...
Age-related psychometric differences in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) opioid use disorder (OUD) diagnostic criteria have been hypothesized, but not been te...
People who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III and reported past 12-month nonmedical use of prescription opioids were included. YAs were 1...
One in 5 people met the DSM-5 OUD diagnostic criteria for OUD within the past 12 months, with the most endorsed criteria being tolerance (17.96%). DIF was identified for 3 criteria, including (1) taki...
These findings suggest that there may be age-related variations in the DSM-5 OUD diagnostic criteria's ability to detect latent OUD. Future research should identify contributing factors and the influe...
There is a scarcity of summarizing data on the epidemiology of insomnia in older persons, especially when diagnosed with international criteria. This study aimed to estimate the prevalence and correla...
Through PubMed/MEDLINE, EMBASE, and Web of Science (WoS), we searched for relevant articles published before June 28, 2023. The risk of bias was weighed using the Joanna Briggs Institute's (JBI's) cri...
We included 18,270 participants across 16 studies. The male/female ratio was 0.89 (12 studies), and the mean age varied from 65.9 to 83.1 years (8 studies). The pooled prevalence of insomnia was 19.6%...
Nearly one in every five old individuals was considered to have insomnia disorder, which was associated with the gender and the existence of mental health and/or somatic conditions....
We registered the protocol in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number: CRD42022344675....
The alternative model of personality disorders (AMPD) traits were designed to maintain continuity with the Section II personality disorder (PD) diagnoses by retaining the same clinical information. Wh...
The Impact of Event Scale-Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders...
A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. Al...
The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarou...
These findings underscore the scale's concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility...